肺癌双特异抗体:机制和临床见解
Wei Chen1, Afang Zhou2, Yunfeng Zhou1
1Department of Thoracic Surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in immunology
|June 13, 2025
概括
双特异性抗体为肺癌患者提供了新的希望,在临床试验和批准的治疗中显示出希望. 本综述探讨了它们的机制,进展和治疗这种耐火性恶性瘤的未来潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肺癌仍然是一个重大挑战,尽管现有治疗方法,但其五年生存率很低.
- 双特异性抗体 (bsAbs) 正因其独特的双结合能力而成为一个有前途的治疗类.
- 最近的批准和正在进行的试验凸显了bsAbs在肺癌治疗中的日益重要.
研究的目的:
- 审查肺癌双特异抗体的结构和作用机制.
- 总结肺癌治疗中双特异抗体的临床进展.
- 分析双特异抗体在肺癌中的应用的挑战和未来方向.
主要方法:
- 在肺癌治疗中对双特异性抗体的文献综述.
- 已批准的两种特异性抗体药物的分析.
- 关于肺癌中双特异抗体的正在进行的临床试验的摘要.
- 讨论挑战和未来的前景.
主要成果:
- 三种双特异性抗体已被批准用于肺癌治疗.
- 许多双特异性抗体正在临床研究安全性和有效性.
- 双特异性抗体显示出新的功能机制和治疗潜力.
结论:
- 双特异性抗体代表了肺癌治疗的重大进展.
- 进一步的研究和临床试验对于优化bsAbs应用至关重要.
- 未来的肺癌治疗可能需要扩大对双特异性抗体的使用.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:25Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K